Sentences with phrase «with changes to their program»

The Desk's current overnight Securities Lending operation will continue with no changes to program terms.

Unsurprisingly, some authors and readers are unhappy with the changes to the program.

Lenders had been hearing bits and pieces of welcome news over the past months of possible condominium approval changes and changes to come for non-borrowing spouses so when it was announced that HUD was issuing a major Mortgagee Letter with changes to the program, at first lenders and borrowers alike were excited.

If all programs did is increasingly bonus higher revenue fares (United already did this with changes to their program for 2012) and provide the option to book any seat desired with points at a fixed - value per point based on fare (in parallel to the award chart) this would be no big deal.

I realize that I am in the minority here, but as an Atlanta based Delta frequent flyer, I am pleased with the changes to the program.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Many customers — who frankly did and would go to Starbucks with no loyalty program just as frequently — are up in arms over their changing the loyalty program from per visit to per dollar spent.

Western Australia's peak industry lobby group has repeated its call for the federal government to come up with credible evidence to support its proposed changes to the 457 visa program for temporary s

Audiences» changing viewing habits are likely one reason for the declining ratings for live award shows like the Oscars, as more and more people cut ties with the cable packages that are often required to watch such programs either on TV or online.

And somehow those meetings lead to partnering with a 25 - year veteran of the CIA's Director of Operations, a Lockheed Martin Program Director for Advanced Systems at Skunk Works, and a former Deputy Assistant Secretary of Defense for Intelligence to start a company to explore «exotic science and technologies» and turn innovative ideas into world - changing products and services.

The changes, and the culture of regular reinvention that enabled them, earned platinum status in Deloitte's Canada's Best - Managed Companies program, a recognition given to firms with seven or more years on the list.

«This is a year of really being an influence and a change maker in an amazing city that's really at the forefront of the revitalization efforts in our entire country,» says Greene Groves concluding her pitch for the program, ending with a paraphrase of the Michigan governor's pitch for Motor City: «Yeah, you can go to another city, but if you want to make a difference, come to Detroit.»

Icahn owns an 82 % stake in CVR Energy, which along with other refining companies, has called for changes to the Renewable Fuel Program to shift the burden of blending biofuels into gasoline away from refiners and further down stream to marketers.

The Frederictoncampus continues tooffer its Activator program, in which studentswork with anentrepreneur to cultivate a business idea.Meanwhile, a new entrepreneurship streamis available to students on the Saint John campus, which also added skills developmentcourses and a social entrepreneurship course.Big changes have come to the Saint John campusthrough some big donations recently.The Pond - Deshpande Centre for Innovationand Entrepreneurship offers courses andmentorship opportunities for students, whilea donation from the Irving family helped funda new library facility.

We try to foster greater innovativeness at our businesses with new programs or processes, we scheme to get in shape by making healthy lifestyle changes, we strive for the good life by trying to accomplish more and be happier.

To that end, we have teamed up with the University of North Carolina's Kenan - Flagler Business School — a recognized leader in online business education — to create an innovative executive certificate program called: Change the World: Leading with PurposTo that end, we have teamed up with the University of North Carolina's Kenan - Flagler Business School — a recognized leader in online business education — to create an innovative executive certificate program called: Change the World: Leading with Purposto create an innovative executive certificate program called: Change the World: Leading with Purpose.

These forward - looking statements include, among other things, statements about full - year 2018 guidance, project milestones, increased opportunities in the market, backlog, bids and change orders outstanding, target projects and revenue opportunity pipeline, to the extent these may be viewed as indicators of future revenues or profitability, the expected impacts of the F2G program and progress toward completing the proposed combination with CB&I and the anticipated benefits of that transaction.

There's an element of psychology at work here in that when we encounter crisis in our lives, we're also programmed to deal with change in a way that, in more normal times when everything seems fine, we tend to reject.

This weekend pays tribute to a specific era, 1985 - 89, and features a host of initiatives like cars with old - school car paint schemes, commemorative ticket and program designs, specially - designed apparel, retro food offerings at the track... unlike, say, baseball or football throw - back games where the only real change is the team's uniforms, Darlington and its partners goes all in.

Other recommendations were popular with the CEOs, as well, such as using cost - savings from changes to the program for «moving bonuses» given to those who relocate for work.

«But all it takes is a couple of dedicated teachers with a little support and guidance to run important research programs that can produce winners in this competition and more importantly kids who are going to go on to become scientists and change the world.»

With a deeper focus in one area, you can continue to grow and develop that skill as programs and needs change.

In early January, Walden Asset Management, a corporate client who uses Vanguard for their 401 (k) program, wrote Vanguard about its proxy voting practices with respect to social and environmental issues like political spending and climate change.

Aimia said it is working on a promotion to earn more miles with existing partners and developing a strategy for how the program will change once the long - term partnership with Air Canada ends.

Our Digital Inclusion Program teaches foster youth basic digital literacy skills and provides them with a laptop and mobile Internet access for five years, two things that most of us take for granted but can be life changing for students who are accustomed to writing essays on their cellphones.

The bipartisan Senate plan would attempt to maintain TPS in return for ending or changing a «diversity» lottery program that has been aimed at allowing up to 50,000 people a year from countries with few emigres to the United States.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«In order to accelerate meaningful corporate and market impact, many corporations are expanding their CVC unit mandates to include traditional minority investments, majority equity investment more consistent with Growth PE, M&A and internal commercial piloting and incubation programs; and compensation structures need to keep pace with these changes,» said Heidi Mason, managing partner of Bell Mason Group and co-founder of CVI ².

To change that, she made a call to the Emerging Technologies Program with the City of Austin's Economic Development DivisioTo change that, she made a call to the Emerging Technologies Program with the City of Austin's Economic Development Divisioto the Emerging Technologies Program with the City of Austin's Economic Development Division.

The Program Agreement with HSBC included a change of control provision that would permit us to terminate such agreement following a change of control of HSBC, which occurred upon closing of the Capital One transaction.

The cluster also helped students at Case Western Reserve with their idea for a flexible electronic price label that lets stores use a software program to change prices with the mere press of a button.

In addition to this training program, Starbucks will work with the community to leverage existing programs that help connect young people with internships, apprenticeships and jobs, and foster the type of dialogue and engagement needed for continued social change.

That's why KPCB is launching ProductWorks, a new program that will provide entrepreneurs with support to create world - changing products.

«Consistent with its pattern for the last two years, the company is on track to complete its regular review and thorough analysis and to announce any changes to the current program by March or April of 2014.

monitoring workforce management programs; establishing compensation policies and practices for service on the Board and its committees, including annually reviewing the appropriate level of director compensation and recommending to the Board any changes to that compensation; developing stock ownership guidelines for directors and executive officers and monitoring compliance with such guidelines; and annually evaluating its performance and its charter.

On Labor Day, Scott Gerber, president and founder of the Young Entrepreneur Council (YEC), hopes to tap into precisely this brand of technology, scale and openness to change the way startup mentorship is done, with the launch of StartupLab, a free virtual mentorship program for young entrepreneurs.

While Trump could initiate some changes to the visa program with executive action, significant shifts would likely need to go through a lengthy formal rulemaking process, said Stephen Yale - Loehr, an immigration expert at Cornell Law School.

Contrast Canada with the United States where needed changes to Social Security and other entitlement programs are held hostage to ongoing political gridlock.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

These include: C$ 4.5 billion to support research, training, and infrastructure at universities and colleges; a Strategic Innovation Fund that will provide C$ 1.26 billion for business innovation in the aerospace and automotive sector; a Connect to Innovate Program that will invest C$ 500 million to bring high - speed Internet to remote and rural communities by 2021; and, C$ 70 million over six years to support agriculture innovation with a focus on climate change, and soil and water conservation.

This includes having in place compliance programs that have been updated so as to be consistent with all of the provisions of the CFPOA including the recent changes.

Changes to the program would require approval by a majority of provinces with majority of the population.

The Ontario government and MaRS Discovery District are helping promising young leaders gain the knowledge, skills and experience they need to make positive social changes in their communities and across the province with an innovative new program.

Similarly to our networks it is important for us to collaborate with other entrepreneurship programs so that together we can influence change.

In the wake of the Cambridge Analytica data misuse scandal, Facebook has announced important changes to its app platform, along with improvements to its official bug bounty program that will incentivize and reward security researchers for hunting down third - party Facebook apps that misuse user data.

With innovative products, online and offline training programs and account based sales consulting, No More Cold Calling works with both small and large businesses who want to change the way they sell to get predictable, measurable resuWith innovative products, online and offline training programs and account based sales consulting, No More Cold Calling works with both small and large businesses who want to change the way they sell to get predictable, measurable resuwith both small and large businesses who want to change the way they sell to get predictable, measurable results.

The Rotman School has close ties to industry, and to stay current with the changing pace of business, the School invites local business leaders to participate in a vital executive - in - residence program.

The Pure Barre client experience in - studio is ever - changing with regular updates to our class choreography and music, as well as the introduction of new classes and programming.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry (R) World (TM); risks related to the collection, storage, transmission, use and disclosure of confidential and personal information;

Consistent with its pattern for the last two years, the Company is on track to complete its regular review and thorough analysis and to announce any changes to the current program by March or April of 2014.